✦ LIBER ✦

PET poised to alter the current paradigm for response assessment of non-Hodgkin's lymphoma

✍ Scribed by Guermazi, A; Juweid, M E

Book ID: 126974912
Publisher: British Institute of Radiology
Year: 2006
Tongue: English
Weight: 63 KB
Volume: 79
Category: Article
ISSN: 0007-1285
DOI: 10.1259/bjr/31368041

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A case of non-Hodgkin’s lymphoma of the

A case of non-Hodgkin’s lymphoma of the ovary: Usefulness of18F-FDG PET for staging and assessment of the therapeutic response

✍ Daisuke Komoto; Yoshihiro Nishiyama; Yuka Yamamoto; Toshihide Monden; Yasuhiro S 📂 Article 📅 2006 🏛 Springer Japan 🌐 English ⚖ 943 KB

Response to Larry R. White's Letter to t

Response to Larry R. White's Letter to the Editor Titled “Comparison of CT, PET, and PET/CT for Staging of Patients with Indolent Non-Hodgkin's Lymphoma: Statistical Errors in Fueger et al. (2009)”

✍ Barbara J. Fueger, Kristen Yeom, Johannes Czernin, James W. Sayre, Michael E. Ph 📂 Article 📅 2012 🏛 Springer-Verlag 🌐 English ⚖ 119 KB

Salvage Surgery for Primary Non-Hodgkin'

Salvage Surgery for Primary Non-Hodgkin's Lymphoma of the Thyroid Gland with Histopathological Complete Response to Radio-Chemotherapy: Report of a Case

✍ Junzo Shimizu; Yoshinori Ishida; Akira Takehara; Takahiro Kinoshita; Yasuhiko Ta 📂 Article 📅 2003 🏛 Springer 🌐 English ⚖ 249 KB

Response to “Role of FDG-PET in the Defi

Response to “Role of FDG-PET in the Definition and Management of Involved-Field Radiation Therapy for Pediatric Hodgkin’s Lymphoma.” Int J Radiat Oncol Biol Phys (2011;80:324–332)

✍ Jianhua Wang; Mei Shi 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 43 KB

Cyclophosphamide, doxorubicin, vincristi

Cyclophosphamide, doxorubicin, vincristine and prednisone chemotherapy and radiotherapy for stage I intermediate or high grade non-Hodgkin's lymphomas: results of a strategy that adapts radiotherapy dose to the response after chemotherapy

✍ Augustinus D.G Krol; Henriëtte W.A Berenschot; Dew Doekharan; Sonja Henzen-Logma 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 97 KB

A phase I trial to assess the value of r

A phase I trial to assess the value of recombinant human granulocyte colony stimulating factor (r-MetHuG-CSF, filgrastim) in accelerating the dose rate of chemotherapy for intermediate and high-grade non-Hodgkin's lymphoma (NHL)

✍ G. M. Smith; J. A. Child; M. H. Cullen; N. P. Bailey; C. M. Woodruffe; J. Fletch 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 571 KB

In a multi-centre phase I study we investigated the possibility of reducing the interval between courses of standard CHOP (cyclophosphamide 750 mg/m2, doxorubicin 50 mg/m', vincristine 2 mgs day 1, and prednisolone 40mglm' days 1-8) from 21 days to 15 days and then 10 days using granulocyte colony s